Mirae Asset Global Investments »

Eyepoint Pharmaceuticals shares owned by Mirae Asset Global Investments

Quarter-by-quarter ownership of Eyepoint Pharmaceuticals (EYPT) shares owned by Mirae Asset Global Investments from 13F filings

Historical chart of Mirae Asset Global Investments investment in Eyepoint Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Eyepoint Pharmaceuticals held by Mirae Asset Global Investments consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Eyepoint Pharmaceuticals by Mirae Asset Global Investments

Quarter filed Position value Share count Share price at filing
2023-12-31 $360k 16k 23.11
2023-09-30 $118k 15k 7.99
2022-09-30 $93k 11k 8.24

More positions owned by Mirae Asset Global Investments

NVIDIA Corporation (NVDA)
Microsoft Corporation (MSFT)
Apple (AAPL)
Amazon (AMZN)
Meta Platforms Cl A (META)
Alphabet Cap Stk Cl A (GOOGL)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Broadcom (AVGO)
Tesla Motors (TSLA)
Alphabet Cap Stk Cl C (GOOG)
Vanguard Scottsdale Fds Vng Rus2000idx (VTWO)
Ishares Tr Core S&p500 Etf (IVV)
Advanced Micro Devices (AMD)
Intuitive Surgical Com New (ISRG)
Qualcomm (QCOM)

View all positions for Mirae Asset Global Investments

Top funds holding Eyepoint Pharmaceuticals

Cormorant Asset Management
Franklin Resources
T. Rowe Price Associates
Vanguard Group
Citadel Advisors
Perceptive Advisors
Millennium Management
Ikarian Capital
Deutsche Bank Aktiengesellschaft
Federated Investors
Fiera Capital Corporation
Laurion Capital Management
Susquehanna International
First Turn Management
UBS Group

View all funds holding Eyepoint Pharmaceuticals